Status:
UNKNOWN
Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder
Lead Sponsor:
New York Medical College
Collaborating Sponsors:
Westchester Medical Center
U.S. Army Medical Research and Development Command
Conditions:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic, Acute
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
Level 2 trauma patients admitted to Westchester Medical Center who consent and meet the inclusion criteria will answer a questionnaire, be tested on Beck Anxiety Index, assessed for vital signs and pr...
Detailed Description
Patients admitted to the Westchester Medical Center as a level 2 trauma patient who meet the admission criteria will be asked to join the study and written consent will be obtained. Every patient who ...
Eligibility Criteria
Inclusion
- Level 2 trauma patients admitted to the trauma floors or trauma ICU at Westchester Medical Center
- Experienced fear at the time of the trauma
Exclusion
- Vulnerable populations, such as pregnant women, prisoners, persons with decisional incapacity.
- History of coronary artery disease, heart failure, prior stroke, heart surgery
- Bood pressure \>160/90
- Acutely psychotic
- Current diagnosis of anorexia nervosa, bulimia
- Current diagnosis of cancer
- Drug abuse or dependence in the preceding 3 months,
- Any unstable medical condition
- Active suicidal/homicidal ideation
- Cannot speak, read, write and understand English at least at 8th grade level.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04071600
Start Date
November 1 2019
End Date
November 1 2022
Last Update
August 28 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Medical College
Valhalla, New York, United States, 10595
2
Westchester Medical Center
Valhalla, New York, United States, 10595